A detailed history of Qube Research & Technologies LTD transactions in Agilon Health, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 707,246 shares of AGL stock, worth $4.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
707,246
Previous 18,938 3634.53%
Holding current value
$4.22 Million
Previous $237,000 1720.25%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$4.76 - $12.93 $3.28 Million - $8.9 Million
688,308 Added 3634.53%
707,246 $4.31 Million
Q4 2023

Feb 13, 2024

BUY
$10.62 - $19.8 $201,121 - $374,972
18,938 New
18,938 $237,000
Q4 2021

Feb 01, 2022

SELL
$21.43 - $27.39 $986,015 - $1.26 Million
-46,011 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$26.15 - $38.72 $1.07 Million - $1.59 Million
41,057 Added 828.76%
46,011 $1.21 Million
Q2 2021

Aug 13, 2021

BUY
$29.14 - $43.25 $144,359 - $214,260
4,954 New
4,954 $201,000

Others Institutions Holding AGL

About agilon health, inc.


  • Ticker AGL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 410,936,000
  • Market Cap $2.45B
  • Description
  • agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon ...
More about AGL
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.